Annual EBITDA
-$11.84 M
-$182.10 K-1.56%
September 30, 2024
Summary
- As of February 8, 2025, NMTC annual EBITDA is -$11.84 million, with the most recent change of -$182.10 thousand (-1.56%) on September 30, 2024.
- During the last 3 years, NMTC annual EBITDA has fallen by -$1.98 million (-20.05%).
- NMTC annual EBITDA is now -197271.67% below its all-time high of -$6000.00, reached on December 31, 2010.
Performance
NMTC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.95 M
-$223.70 K-8.19%
September 30, 2024
Summary
- As of February 8, 2025, NMTC quarterly EBITDA is -$2.95 million, with the most recent change of -$223.70 thousand (-8.19%) on September 30, 2024.
- Over the past year, NMTC quarterly EBITDA has increased by +$52.00 thousand (+1.73%).
- NMTC quarterly EBITDA is now -590800.00% below its all-time high of -$500.00, reached on December 31, 2010.
Performance
NMTC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.84 M
+$52.00 K+0.44%
September 30, 2024
Summary
- As of February 8, 2025, NMTC TTM EBITDA is -$11.84 million, with the most recent change of +$52.00 thousand (+0.44%) on September 30, 2024.
- Over the past year, NMTC TTM EBITDA has dropped by -$182.00 thousand (-1.56%).
- NMTC TTM EBITDA is now -422839.29% below its all-time high of -$2800.00, reached on June 30, 2010.
Performance
NMTC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NMTC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.6% | +1.7% | -1.6% |
| 3 y3 years | -20.1% | -6.1% | -10.6% |
| 5 y5 years | -83.1% | -53.1% | -61.9% |
NMTC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | at low | -116.2% | +14.4% | -33.4% | +10.6% |
| 5 y | 5-year | -95.2% | at low | -522.3% | +14.4% | -95.2% | +10.6% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +14.4% | <-9999.0% | +10.6% |
NeuroOne Medical Technologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$11.84 M(+1.6%) | -$2.95 M(+8.2%) | -$11.84 M(-0.4%) |
| Jun 2024 | - | -$2.73 M(-3.3%) | -$11.89 M(-5.7%) |
| Mar 2024 | - | -$2.83 M(-15.2%) | -$12.62 M(-4.7%) |
| Dec 2023 | - | -$3.33 M(+10.8%) | -$13.24 M(+13.6%) |
| Sep 2023 | -$11.66 M(+17.6%) | -$3.01 M(-12.9%) | -$11.66 M(+16.4%) |
| Jun 2023 | - | -$3.45 M(+0.0%) | -$10.02 M(+7.8%) |
| Mar 2023 | - | -$3.45 M(+97.4%) | -$9.30 M(+4.7%) |
| Dec 2022 | - | -$1.75 M(+27.9%) | -$8.88 M(-10.4%) |
| Sep 2022 | -$9.91 M(+0.5%) | -$1.37 M(-49.9%) | -$9.91 M(-11.2%) |
| Jun 2022 | - | -$2.73 M(-9.9%) | -$11.17 M(-1.8%) |
| Mar 2022 | - | -$3.03 M(+8.9%) | -$11.37 M(+6.1%) |
| Dec 2021 | - | -$2.78 M(+6.2%) | -$10.71 M(+8.6%) |
| Sep 2021 | -$9.86 M(+62.6%) | -$2.62 M(-10.6%) | -$9.86 M(+27.8%) |
| Jun 2021 | - | -$2.93 M(+23.4%) | -$7.72 M(+8.5%) |
| Mar 2021 | - | -$2.37 M(+22.5%) | -$7.12 M(+17.1%) |
| Dec 2020 | - | -$1.94 M(+308.1%) | -$6.08 M(+0.1%) |
| Sep 2020 | -$6.07 M(-6.2%) | -$474.80 K(-79.6%) | -$6.07 M(-12.5%) |
| Jun 2020 | - | -$2.33 M(+74.5%) | -$6.94 M(+7.3%) |
| Mar 2020 | - | -$1.33 M(-30.8%) | -$6.46 M(-11.6%) |
| Dec 2019 | - | -$1.93 M(+43.7%) | -$7.32 M(+13.1%) |
| Sep 2019 | -$6.47 M(+48.6%) | -$1.34 M(-27.7%) | -$6.47 M(+26.2%) |
| Jun 2019 | - | -$1.86 M(-15.1%) | -$5.13 M(+21.4%) |
| Mar 2019 | - | -$2.19 M(+101.8%) | -$4.22 M(+32.2%) |
| Dec 2018 | - | -$1.08 M(+13.9%) | -$3.19 M(-26.8%) |
| Sep 2018 | -$4.35 M(+19.4%) | - | - |
| Jun 2018 | - | -$951.60 K(-17.9%) | -$4.36 M(+0.3%) |
| Mar 2018 | - | -$1.16 M(-14.8%) | -$4.35 M(+17.5%) |
| Dec 2017 | -$3.65 M | -$1.36 M(+53.0%) | -$3.70 M(+46.7%) |
| Sep 2017 | - | -$889.50 K(-5.4%) | -$2.52 M(+54.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$940.20 K(+84.0%) | -$1.63 M(+130.7%) |
| Mar 2017 | - | -$511.00 K(+181.1%) | -$708.80 K(+250.5%) |
| Dec 2016 | -$32.60 K(+5.5%) | -$181.80 K(+9468.4%) | -$202.20 K(+592.5%) |
| Sep 2016 | - | -$1900.00(-86.5%) | -$29.20 K(-2.3%) |
| Jun 2016 | - | -$14.10 K(+220.5%) | -$29.90 K(-13.3%) |
| Mar 2016 | - | -$4400.00(-50.0%) | -$34.50 K(-13.5%) |
| Dec 2015 | -$30.90 K(-13.9%) | -$8800.00(+238.5%) | -$39.90 K(-2.7%) |
| Sep 2015 | - | -$2600.00(-86.1%) | -$41.00 K(-7.9%) |
| Jun 2015 | - | -$18.70 K(+90.8%) | -$44.50 K(+6.5%) |
| Mar 2015 | - | -$9800.00(-1.0%) | -$41.80 K(+16.4%) |
| Dec 2014 | -$35.90 K(+43.0%) | -$9900.00(+62.3%) | -$35.90 K(+25.5%) |
| Sep 2014 | - | -$6100.00(-61.9%) | -$28.60 K(+5.1%) |
| Jun 2014 | - | -$16.00 K(+310.3%) | -$27.20 K(+4.6%) |
| Mar 2014 | - | -$3900.00(+50.0%) | -$26.00 K(+3.6%) |
| Dec 2013 | -$25.10 K(+83.2%) | -$2600.00(-44.7%) | -$25.10 K(+5.0%) |
| Sep 2013 | - | -$4700.00(-68.2%) | -$23.90 K(0.0%) |
| Jun 2013 | - | -$14.80 K(+393.3%) | -$23.90 K(+109.6%) |
| Mar 2013 | - | -$3000.00(+114.3%) | -$11.40 K(-18.0%) |
| Dec 2012 | -$13.70 K(-50.0%) | -$1400.00(-70.2%) | -$13.90 K(-50.4%) |
| Sep 2012 | - | -$4700.00(+104.3%) | -$28.00 K(+2.2%) |
| Jun 2012 | - | -$2300.00(-58.2%) | -$27.40 K(+4.2%) |
| Mar 2012 | - | -$5500.00(-64.5%) | -$26.30 K(-4.4%) |
| Dec 2011 | -$27.40 K(+356.7%) | -$15.50 K(+278.0%) | -$27.50 K(+120.0%) |
| Sep 2011 | - | -$4100.00(+241.7%) | -$12.50 K(-8.1%) |
| Jun 2011 | - | -$1200.00(-82.1%) | -$13.60 K(-10.5%) |
| Mar 2011 | - | -$6700.00(+1240.0%) | -$15.20 K(+78.8%) |
| Dec 2010 | -$6000.00 | -$500.00(-90.4%) | -$8500.00(+6.3%) |
| Sep 2010 | - | -$5200.00(+85.7%) | -$8000.00(+185.7%) |
| Jun 2010 | - | -$2800.00 | -$2800.00 |
FAQ
- What is NeuroOne Medical Technologies annual EBITDA?
- What is the all time high annual EBITDA for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies annual EBITDA year-on-year change?
- What is NeuroOne Medical Technologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies quarterly EBITDA year-on-year change?
- What is NeuroOne Medical Technologies TTM EBITDA?
- What is the all time high TTM EBITDA for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies TTM EBITDA year-on-year change?
What is NeuroOne Medical Technologies annual EBITDA?
The current annual EBITDA of NMTC is -$11.84 M
What is the all time high annual EBITDA for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high annual EBITDA is -$6000.00
What is NeuroOne Medical Technologies annual EBITDA year-on-year change?
Over the past year, NMTC annual EBITDA has changed by -$182.10 K (-1.56%)
What is NeuroOne Medical Technologies quarterly EBITDA?
The current quarterly EBITDA of NMTC is -$2.95 M
What is the all time high quarterly EBITDA for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high quarterly EBITDA is -$500.00
What is NeuroOne Medical Technologies quarterly EBITDA year-on-year change?
Over the past year, NMTC quarterly EBITDA has changed by +$52.00 K (+1.73%)
What is NeuroOne Medical Technologies TTM EBITDA?
The current TTM EBITDA of NMTC is -$11.84 M
What is the all time high TTM EBITDA for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high TTM EBITDA is -$2800.00
What is NeuroOne Medical Technologies TTM EBITDA year-on-year change?
Over the past year, NMTC TTM EBITDA has changed by -$182.00 K (-1.56%)